PD1 mRNA may predict response to anti-PD1 monotherapy across cancer typesSeptember 4, 2018Immuno-oncologyMelanomaLung CancerRenal Cell Carcinoma
Nivolumab plus ipilimumab effective in melanoma brain metastasesAugust 27, 2018MelanomaCNS/Brain CancerImmuno-oncology
Adding checkpoint inhibitors to radiotherapy requires particular caution in this one scenarioAugust 24, 2018Immuno-oncologyLung CancerCNS/Brain CancerMelanoma
Melanoma survival shorter in those given high dose glucocorticoids for ipilimumab-induced hypophysitisJuly 18, 2018ImmunotherapyMelanomaPatient & Survivor Care
Immunotherapies extend survival for melanoma patients with brain metastasesJuly 12, 2018Immuno-oncologyNeuro-oncologyCNS/Brain CancerMelanoma
Registry data provide evidence that Mohs surgery remains underutilizedJune 22, 2018Nonmelanoma Skin CancerMelanoma
IMPACT study: Matched targeted therapy improves survival in advanced cancerJune 4, 2018MelanomaGastroenterologyBreast CancerLung CancerGastrointestinal Cancer
Is cancer immunotherapy more effective in men than women?May 16, 2018Immuno-oncologyImmunotherapyGenitourinary CancerGastroenterologyRenal Cell CarcinomaMelanomaLung Cancer
Checkpoint inhibitors get to patients quicklyMay 10, 2018Renal Cell CarcinomaImmuno-oncologyLung CancerMelanoma
